Neuroprotection for retinal detachment

International Ophthalmology Clinics

Volumn 53, Issue 4, 2013, Pages 105-117

  Huckfeldt, Rachel M ^a   Vavvas, Demetrios G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; DEXAMETHASONE; DNA NUCLEOTIDYLEXOTRANSFERASE; HIGH MOBILITY GROUP B1 PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TAUROURSODEOXYCHOLIC ACID; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; BLUNT TRAUMA; CELLULAR STRESS RESPONSE; CHROMATIN CONDENSATION; DIABETIC RETINOPATHY; DNA FRAGMENTATION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; INTERMEDIATE FILAMENT; NECROPTOSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PHOTORECEPTOR CELL; PHOTORECEPTOR OUTER SEGMENT; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; SCLERA BUCKLING PROCEDURE; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TIME TO TREATMENT; TRANSMISSION ELECTRON MICROSCOPY; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY;

APOPTOSIS; HUMANS; NEUROPROTECTIVE AGENTS; PHOTORECEPTOR CELLS, VERTEBRATE; RETINAL DETACHMENT;

EID: 84885441160     PISSN: 00208167     EISSN: 15369617     Source Type: Journal    
DOI: 10.1097/IIO.0b013e31829cf08d     Document Type: Article

References (81)

1. Cox MS, Schepens CL, Freeman HM. Retinal detachment due to ocular contusion. Arch Ophthalmol. 1966;76:678-685
2. Weidenthal DT, Schepens CL. Peripheral fundus changes associated with ocular contusion. Am J Ophthalmol. 1966;62:465-477
3. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85: 845-881
4. Haimann MH, Burton TC, Brown CK. Epidemiology of retinal detachment. Arch Ophthalmol. 1982;100:289-292
5. Wilkes SR, Beard CM, Kurland LT, et al. The incidence of retinal detachment in Rochester, Minnesota, 1970-1978. Am J Ophthalmol. 1982;94:670-673
6. Mitry D, Charteris DG, Yorston D, et al. The epidemiology and socioeconomic associations of retinal detachment in Scotland: A two-year prospective populationbased study. Invest Ophthalmol Vis Sci. 2010;51:4963-4968
7. Winslow RL, Tasman W. Juvenile rhegmatogenous retinal detachment. Ophthalmology. 1978;85:607-618
8. Nagpal M, Nagpal K, Rishi P, et al. Juvenile rhegmatogenous retinal detachment. Indian J Ophthalmol. 2004;52:297-302
9. Maguire JI, Benson WE. Retinal injury and detachment in boxers. JAMA. 1986;255:2451-2453
10. Lesniak SP, Bauza A, Son JH, et al. Twelve-year review of pediatric traumatic open globe injuries in an urban U.S. population. J Pediatr Ophthalmol Strabismus. 2012;49: 73-79
11. Tok O, Tok L, Ozkaya D, et al. Epidemiological characteristics and visual outcome after open globe injuries in children. J AAPOS. 2011;15:556-561
12. Kanoff JM, Turalba AV, Andreoli MT, et al. Characteristics and outcomes of workrelated open globe injuries. Am J Ophthalmol. 2010;150:265-269.e2
13. Yalcin Tok O, Tok L, Eraslan E, et al. Prognostic factors influencing final visual acuity in open globe injuries. J Trauma. 2011;71:1794-1800
14. Heimann H, Bartz-Schmidt KU, Bornfeld N, et al. Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment: A prospective randomized multicenter clinical study. Ophthalmology. 2007;114:2142-2154
15. Hassan TS, Sarrafizadeh R, Ruby AJ, et al. The effect of duration of macular detachment on results after the scleral buckle repair of primary, macula-off retinal detachments. Ophthalmology. 2002;109:146-152
16. Sun Q, Sun T, Xu Y, et al. Primary vitrectomy versus scleral buckling for the treatment of rhegmatogenous retinal detachment: A meta-Analysis of randomized controlled clinical trials. Curr Eye Res. 2012;37:492-499
17. Sodhi A, Leung LS, Do DV, et al. Recent trends in the management of rhegmatogenous retinal detachment. Surv Ophthalmol. 2008;53:50-67
18. Campo RV, Sipperley JO, Sneed SR, et al. Pars plana vitrectomy without scleral buckle for pseudophakic retinal detachments. Ophthalmology. 1999;106:1811-1815; discussion 1816
19. Cardillo JA, Stout JT, LaBree L, et al. Post-Traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology. 1997;104:1166-1173
20. Nagasaki H, Shinagawa K, Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res. 1998;17:77-98
21. Tseng W, Cortez RT, Ramirez G, et al. Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery. Am J Ophthalmol. 2004;137:1105-1115
22. Leiderman YI, Miller JW. Proliferative vitreoretinopathy: Pathobiology and therapeutic targets. Semin Ophthalmol. 2009;24:62-69
23. Rojas J, Fernandez I, Pastor JC, et al. A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2013;54:1665-1678
24. Cook B, Lewis GP, Fisher SK, et al. Apoptotic photoreceptor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci. 1995;36:990-996
25. Erickson PA, Fisher SK, Anderson DH, et al. Retinal detachment in the cat: The outer nuclear and outer plexiform layers. Invest Ophthalmol Vis Sci. 1983;24:927-942
26. Zacks DN, Hanninen V, Pantcheva M, et al. Caspase activation in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci. 2003;44:1262-1267
27. Fisher SK, Lewis GP, Linberg KA, et al. Cellular remodeling in mammalian retina: Results from studies of experimental retinal detachment. Prog Retin Eye Res. 2005;24: 395-431
28. Lewis GP, Erickson PA, Anderson DH, et al. Opsin distribution and protein incorporation in photoreceptors after experimental retinal detachment. Exp Eye Res. 1991;53:629-640
29. Lewis GP, Linberg KA, Fisher SK. Neurite outgrowth from bipolar and horizontal cells after experimental retinal detachment. Invest Ophthalmol Vis Sci. 1998;39:424-434
30. Sethi CS, Lewis GP, Fisher SK, et al. Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2005;46:329-342
31. Hagimura N, Suto K, Iida T, et al. Optical coherence tomography of the neurosensory retina in rhegmatogenous retinal detachment. Am J Ophthalmol. 2000;129: 186-190
32. Wolfensberger TJ, Gonvers M. Optical coherence tomography in the evaluation of incomplete visual acuity recovery after macula-off retinal detachments. Graefes Arch Clin Exp Ophthalmol. 2002;240:85-89
33. Nakanishi H, Hangai M, Unoki N, et al. Spectral-domain optical coherence tomography imaging of the detached macula in rhegmatogenous retinal detachment. Retina. 2009;29:232-242
34. Wakabayashi T, Oshima Y, Fujimoto H, et al. Foveal microstructure and visual acuity after retinal detachment repair: Imaging analysis by Fourier-domain optical coherence tomography. Ophthalmology. 2009;116:519-528
35. Cho M, Witmer MT, Favarone G, et al. Optical coherence tomography predicts visual outcome in macula-involving rhegmatogenous retinal detachment. Clin Ophthalmol. 2012;6:91-96
36. Hahn P, Lindsten T, Ying GS, et al. Proapoptotic bcl-2 family members, Bax and Bak, are essential for developmental photoreceptor apoptosis. Invest Ophthalmol Vis Sci. 2003;44:3598-3605
37. Young RW. Cell death during differentiation of the retina in the mouse. J Comp Neurol. 1984;229:362-373
38. Penfold PL, Provis JM. Cell death in the development of the human retina: Phagocytosis of pyknotic and apoptotic bodies by retinal cells. Graefes Arch Clin Exp Ophthalmol. 1986;224:549-553
39. Chang CJ, Lai WW, Edward DP, et al. Apoptotic photoreceptor cell death after traumatic retinal detachment in humans. Arch Ophthalmol. 1995;113:880-886
40. Arroyo JG, Yang L, Bula D, et al. Photoreceptor apoptosis in human retinal detachment. Am J Ophthalmol. 2005;139:605-610
41. Chang GQ, Hao Y, Wong F. Apoptosis: Final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron. 1993;11:595-605
42. Sancho-Pelluz J, Arango-Gonzalez B, Kustermann S, et al. Photoreceptor cell death mechanisms in inherited retinal degeneration. Mol Neurobiol. 2008;38:253-269
43. Dunaief JL, Dentchev T, Ying GS, et al. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol. 2002;120:1435-1442
44. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119: 493-501
45. Hisatomi T, Sakamoto T, Murata T, et al. Relocalization of apoptosis-inducing factor in photoreceptor apoptosis induced by retinal detachment in vivo. Am J Pathol. 2001; 158:1271-1278
46. Yang L, Bula D, Arroyo JG, et al. Preventing retinal detachment- Associated photoreceptor cell loss in Bax-deficient mice. Invest Ophthalmol Vis Sci. 2004;45:648-654
47. Galluzzi L, Vitale I, Abrams JM, et al. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012;19:107-120
48. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 2004;5:897-907
49. Zacks DN, Zheng QD, Han Y, et al. FAS-mediated apoptosis and its relation to intrinsic pathway activation in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci. 2004;45:4563-4569
50. Zacks DN, Boehlke C, Richards AL, et al. Role of the Fas-signaling pathway in photoreceptor neuroprotection. Arch Ophthalmol. 2007;125:1389-1395
51. Nakazawa T, Kayama M, Ryu M, et al. Tumor necrosis factor-Alpha mediates photoreceptor death in a rodent model of retinal detachment. Invest Ophthalmol Vis Sci. 2011;52:1384-1391
52. Nakazawa T, Matsubara A, Noda K, et al. Characterization of cytokine responses to retinal detachment in rats. Mol Vis. 2006;12:867-878
53. Hisatomi T, Sakamoto T, Goto Y, et al. Critical role of photoreceptor apoptosis in functional damage after retinal detachment. Curr Eye Res. 2002;24:161-172
54. Pockros PJ, Schiff ER, Shiffman ML, et al. Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C. Hepatology. 2007;46:324-329
55. Shiffman ML, Pockros P, McHutchison JG, et al. Clinical trial: The efficacy and safety of oral PF-03491390, a pancaspase inhibitor-A randomized placebo-controlled study in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2010;31:969-978
56. Besirli CG, Chinskey ND, Zheng QD, et al. Inhibition of retinal detachment-induced apoptosis in photoreceptors by a small peptide inhibitor of the fas receptor. Invest Ophthalmol Vis Sci. 2010;51:2177-2184
57. Mantopoulos D, Murakami Y, Comander J, et al. Tauroursodeoxycholic acid (TUDCA) protects photoreceptors from cell death after experimental retinal detachment. PLoS One. 2011;6:e24245
58. Zadro-Lamoureux LA, Zacks DN, Baker AN, et al. XIAP effects on retinal detachment- induced photoreceptor apoptosis [corrected]. Invest Ophthalmol Vis Sci. 2009;50: 1448-1453
59. Zacks DN, Han Y, Zeng Y, et al. Activation of signaling pathways and stress-response genes in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci. 2006;47:1691-1695
60. Nakazawa T, Hisatomi T, Nakazawa C, et al. Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci USA. 2007;104:2425-2430
61. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, et al. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatology. 1995;21:1465-1468
62. Laster SM, Wood JG, Gooding LR. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol. 1988;141:2629-2634
63. Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1:112-119
64. Huckfeldt and Vavvas www.internat-ophthalmology.com 64. Holler N, Zaru R, Micheau O, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000; 1:489-495
65. Vandenabeele P, Declercq W, Van Herreweghe F, et al. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal. 2010;3:re4
66. Vandenabeele P, Galluzzi L, Vanden Berghe T, et al. Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat Rev Mol Cell Biol. 2010;11:700-714
67. Arimura N, Ki-i Y, Hashiguchi T, et al. Intraocular expression and release of highmobility group box 1 protein in retinal detachment. Lab Invest. 2009;89:278-289
68. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191-195
69. Murakami Y, Miller JW, Vavvas DG. RIP kinase-mediated necrosis as an alternative mechanisms of photoreceptor death. Oncotarget. 2011;2:497-509
70. Trichonas G, Murakami Y, Thanos A, et al. Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc Natl Acad Sci USA. 2010;107:21695-21700
71. Nakazawa T, Takeda M, Lewis GP, et al. Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin. Invest Ophthalmol Vis Sci. 2007;48:2760-2768
72. Zeng HY, Zhu XA, Zhang C, et al. Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice. Invest Ophthalmol Vis Sci. 2005;46:2992-2999
73. Roh MI, Murakami Y, Thanos A, et al. an ROS scavenger, ameliorates photoreceptor cell death after experimental retinal detachment. Invest Ophthalmol Vis Sci. 2011;52: 3825-3831
74. Moysidis SN, Thanos A, Vavvas DG. Mechanisms of inflammation in proliferative vitreoretinopathy: From bench to bedside. Mediators Inflamm. 2012;2012:815937
75. Limb GA, Alam A, Earley O, et al. Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr Eye Res. 1994;13:791-798
76. Limb GA, Hollifield RD, Webster L, et al. Soluble TNF receptors in vitreoretinal proliferative disease. Invest Ophthalmol Vis Sci. 2001;42:1586-1591
77. Symeonidis C, Papakonstantinou E, Androudi S, et al. Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: Correlation with extent, duration of RRD and PVR grade. Cytokine. 2012; 59:184-190
78. Lewis GP, Charteris DG, Sethi CS, et al. The ability of rapid retinal reattachment to stop or reverse the cellular and molecular events initiated by detachment. Invest Ophthalmol Vis Sci. 2002;43:2412-2420
79. Ross WH, Kozy DW. Visual recovery in macula-off rhegmatogenous retinal detachments. Ophthalmology. 1998;105:2149-2153
80. Chong DY, Boehlke CS, Zheng QD, et al. Interleukin-6 as a photoreceptor neuroprotectant in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci. 2008;49:3193-3200
81. Besirli CG, Chinskey ND, Zheng QD, et al. Autophagy activation in the injured photoreceptor inhibits fas-mediated apoptosis. Invest Ophthalmol Vis Sci. 2011;52: 4193-4199